DNMT3B and type 2 diabetes mellitus: In agreement with cells from individuals with T2D, both DNMT3B and DNMT1 levels were decreased at day 7 versus day 3 in VPS39-silenced cells (Fig. 6b and Supplementary Fig. 5b).